Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study.
Beiert T, Knappe V, Zietzer A, Schmidt V, Pürerfellner H, Sommer P, Sohns C, Veltmann C, Steven D, Chun KJ, Maury P, Gandjbakhch E, Laredo M, Willems S, Borlich M, Füting A, Spittler R, Richter S, Schade A, Kuniss M, Wunderlich C, Shin DI, Meininghaus DG, Bonsels M, Reek D, Wiegand U, Bauer A, Metzner A, Eckardt L, Krahnefeld O, Sticherling C, Kühne M, Nguyen DQ, Roten L, Linz D, van der Voort P, Mulder BA, Vijgen J, Almorad A, Guenancia C, Fauchier L, Boveda S, De Greef Y, Da Costa A, Jais P, Milhem A, Jesel L, Garcia R, Poty H, Khoueiry Z, Seitz J, Laborderie J, Mechulan A, Brigadeau F, Zhao A, Saludas Y, Piot O, Ahluwalia N, Martin CA, Chen J, Antolic B, Leventopoulos G, Özcan EE, Yorgun H, Cay S, Yalin K, Botros MS, Jędrzejczyk-Patej E, Inaba O, Okumura K, Ejima K, Khakpour H, Catanzaro JN, Reddy V, Natale A, Blessberger H, Yang B, Vogler J, Kuck KH, Merino JL, Keelani A, Heeger CH, Popescu SS, Tilz RR.
Beiert T, et al. Among authors: nguyen dq.
Europace. 2025 Oct 7;27(10):euaf212. doi: 10.1093/europace/euaf212.
Europace. 2025.
PMID: 41133846
Free PMC article.
No abstract available.